Post‐injury baicalein improves histological and functional outcomes and reduces inflammatory cytokines after experimental traumatic brain injury
- 1 December 2008
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 155 (8), 1279-1296
- https://doi.org/10.1038/bjp.2008.345
Abstract
Traumatic brain injury (TBI) triggers a complex series of inflammatory responses that contribute to secondary tissue damage. The aim of this study was to investigate the effect of baicalein, a flavonoid possessing potent anti-inflammatory properties, on functional and histological outcomes and inflammatory cytokine expression, following TBI in rats. Rats subjected to controlled cortical impact injury were injected with baicalein (30 mg kg(-1)) or vehicle immediately after injury or daily for 4 days. Neurological status was evaluated using the rotarod, adhesive removal, modified neurological severity scores and beam walk tests. Contusion volume and neuronal degeneration were measured using cresyl violet and FluoroJade B (FJB) histochemistry. Levels of tumour necrosis factor-alpha (TNF-alpha), interleukin-1 beta (IL-1 beta) and interleukin-6 (IL-6) mRNA and protein were assessed by real-time quantitative reverse transcriptase-PCR, enzyme-linked immunosorbent assay and immunohistochemistry. Single-dose and multiple-dose treatment with baicalein significantly improved functional recovery and reduced contusion volumes up to day 28 post-injury, although multiple-dose baicalein was the more effective treatment. Single-dose baicalein also significantly reduced the number of degenerating neurons (31%) on post-injury day 1 as indicated by FJB staining. These changes were associated with significantly decreased levels, at the contusion site, of TNF-alpha, IL-1 beta and IL-6 mRNA at 6 h, and cytokine protein on day 1 post-injury. Post-injury treatment with baicalein improved functional and histological outcomes and reduced induction of proinflammatory cytokines in rat TBI. The neuroprotective effect of baicalein may be related to a decreased inflammatory response following the injury.Keywords
This publication has 64 references indexed in Scilit:
- Lovastatin improves histological and functional outcomes and reduces inflammation after experimental traumatic brain injuryLife Sciences, 2007
- Rapid glia expression and release of proinflammatory cytokines in experimental Klebsiella pneumoniae meningoencephalitisExperimental Neurology, 2007
- Baicalein and 12/15-Lipoxygenase in the Ischemic BrainStroke, 2006
- Baicalein attenuates methamphetamine-induced loss of dopamine transporter in mouse striatumToxicology, 2006
- Inhibition of microglial activation by the herbal flavonoid baicalein attenuates inflammation-mediated degeneration of dopaminergic neuronsJournal of Neural Transmission, 2004
- Administration of Either Anti-Intercellular Adhesion Molecule-1 or a Nonspecific Control Antibody Improves Recovery after Traumatic Brain Injury in the RatJournal of Neurotrauma, 2002
- Evaluation of the Anti-Inflammatory Effect of Baicalein on Dextran Sulfate Sodium-Induced Colitis in MicePlanta Medica, 2002
- Cytokines and acute neurodegenerationNature Reviews Neuroscience, 2001
- Interleukin-1 Receptor Antagonist Attenuates Regional Neuronal Cell Death and Cognitive Dysfunction after Experimental Brain InjuryJournal of Cerebral Blood Flow & Metabolism, 1999
- Soluble ICAM-1 in CSF Coincides with the Extent of Cerebral Damage in Patients with Severe Traumatic Brain InjuryJournal of Neurotrauma, 1998